Europe Respiratory Diagnostics Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
1.92 Billion
USD
3.40 Billion
2021
2029
 Período de previsão |
2022 –2029 |
 Tamanho do mercado (ano base ) | USD 1.92 Billion |
 Tamanho do mercado ( Ano de previsão) | USD 3.40 Billion |
 CAGR |
% |
| Principais participantes do mercado |
Europe Respiratory Diagnostics Market, By Product & Services (Instruments and Devices, Assays and Reagents and Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests and Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis and Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) – Industry Trends and Forecast to 2029
Europe Respiratory Diagnostics Market Analysis and Size
The Europe respiratory diagnostics market is expected to witness significant growth during the forecast period. The global respiratory diagnostics market has been treading on a healthy growth path. Respiratory diagnostics consists of a principal part in the therapeutic innovation area. The rising prevalence of respiratory diseases has set a major concern for accurate disease diagnosis and hence paved the way for the respiratory diagnostics market growth.
Data Bridge Market Research analyses a growth rate in the Europe respiratory diagnostics market in the forecast period 2022-2029. The expected CAGR of Europe respiratory diagnostics market is tend to be around 7.40% in the mentioned forecast period. The market was valued at USD 1.92 billion in 2021, and it would grow upto USD 3.4 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Respiratory diagnostics play a significant role in the medical technology sector. It entails the clinical evaluation of various respiratory conditions such as bronchitis, asthma, COPD, and pulmonary fibrosis, among others, using various mechanical, imaging, and molecular diagnostic tests. Spirometry, computed tomography, oximetry, transcutaneous carbon dioxide monitoring, chest X-ray, sniff nasal inspiratory pressure (SNIP), and other types of respiratory diagnostics are included. Various technological advancements in respiratory diagnostic testing have paved the way for market growth, including the incorporation of artificial intelligence and the use of the internet of things (IoT), among others.
Europe Respiratory Diagnostics Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Product & Services (Instruments and Devices, Assays and Reagents and Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests and Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis and Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) |
|
Countries Covered |
U.S., Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe |
|
Market Players Covered |
BD (U.S.), COSMED srl (Italy), Abbott (U.S.), NIHON KOHDEN CORPORATION (Japan), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GENERAL ELECTRIC COMPANY (U.S.), Koninklijke Philips N.V. (Netherlands), Medtronic (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), MGC Diagnostics Corporation (U.S.), Masimo (U.S.), bioMérieux SA (France), Carestream Health (U.S.), VYAIRE (U.S.), Seegene Inc.(South Korea) and ResMed (U.S.) |
|
Market Opportunities |
|
Europe Respiratory Diagnostics Market Dynamics
Drivers
- Growing Rate of Diseases
The rising prevalence of tuberculosis and lung cancer are driving the market growth at a fast pace. In 2020, many more people died from TB, with far fewer people being diagnosed and treated or provided with TB preventive treatment compared with 2019, and overall spending on essential TB services falling.
- Higher Demand of Hospitals
The rising demand of hospitals increase the market growth rapidly. Most respiratory disease diagnostics are majorly carried out in hospitals as they are very complex and it requires technologically advanced products and thus this is driving the market for hospital/clinical laboratories.
Opportunities
- Increased Geriatric Population
The rising number of elderly population and associated comorbid conditions such as cough issues, deteriorating respiratory conditions, community-acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease and non-pneumonic respiratory tract infection tend to create opportunities of Europe respiratory diagnostics market.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to use these diagnostic techniques could curb the growth of the Europe respiratory diagnostics market over a forecast period.
- High Cost
The huge expenditure required for setting up these techniques surely hamper the market growth. Several market players make huge investment in installing new and advanced machines to faster the process and in return the cost is increased.
This Europe respiratory diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe respiratory diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Europe Respiratory Diagnostics Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.
In the post-pandemic era, COVID-19 is expected to positively impact the ultr low freezers market, attributing to the increasing number of biobanks and plasma treatments.
Europe Respiratory Diagnostics Market Scope
The Europe respiratory diagnostics market is segmented on the basis of product and services, test type, diseases, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Instruments and Devices
- Assays and Reagents
- Services and Software
Test Type
- Traditional Diagnostic Tests
- Mechanical Tests
- Imaging Tests
- Molecular Diagnostic Tests
Diseases
- Chronic Obstructive Pulmonary Disease (COPD)
- Lung Cancer
- Asthma
- Tuberculosis
- Bronchitis
- Pulmonary Fibrosis
- Other Diseases
End User
- Hospital/Clinical Laboratories
- Physician Offices
- Reference Laboratories
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Other
Europe Respiratory Diagnostics Market Regional Analysis/Insights
The Europe respiratory diagnostics market is analysed and market size insights and trends are provided by product and services, test type, diseases, end-user and distribution channel as referenced above.
The major countries covered in the respiratory diagnostics market report are the U.S., Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
Germany's respiratory diagnostics market is expanding primarily as a result of increased focus on the high prevalence of disorders among the elderly. Rising social media concerns are also significant growth drivers for the market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Respiratory Diagnostics Market Share Analysis
The Europe respiratory diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe respiratory diagnostics market
Key players operating in the Europe respiratory diagnostics market include:
- BD (U.S.)
- COSMED srl (Italy)
- Abbott (U.S.)
- NIHON KOHDEN CORPORATION (Japan)
- Drägerwerk AG & Co. KGaA (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- GENERAL ELECTRIC COMPANY (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Medtronic (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- MGC Diagnostics Corporation (U.S.)
- Masimo (U.S.)
- bioMérieux SA (France)
- Carestream Health (U.S.)
- VYAIRE (U.S.)
- Seegene Inc. (South Korea)
- ResMed (U.S.)
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
